Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eledon Pharmaceuticals (ELDN) Treasury Shares (2018 - 2025)

Eledon Pharmaceuticals filings provide 2 years of Treasury Shares readings, the most recent being $40953.0 for Q4 2015.

  • On a quarterly basis, Treasury Shares fell 25.0% to $40953.0 in Q4 2015 year-over-year; TTM through Dec 2015 was $40953.0, a 25.0% decrease, with the full-year FY2015 number at $40953.0, down 25.0% from a year prior.
  • Treasury Shares hit $40953.0 in Q4 2015 for Eledon Pharmaceuticals, down from $54604.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $54604.0 in Q4 2014 to a low of $40953.0 in Q4 2015.